These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8419049)

  • 1. HPLC micro-method for determining delta-aminolevulinic acid in plasma.
    Tomokuni K; Ichiba M; Hirai Y
    Clin Chem; 1993 Jan; 39(1):169-70. PubMed ID: 8419049
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on measurement of delta-aminolevulinic acid in plasma by high-performance liquid chromatography.
    Miyajima K; Hirata M; Yoshida T; Kosaka H; Okayama A
    J Chromatogr B Biomed Appl; 1994 Apr; 654(2):165-9. PubMed ID: 8044276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro assay for urinary delta-aminolevulinic acid and porphobilinogen by high-performance liquid chromatography with pre-column derivatization.
    Ho JW
    J Chromatogr; 1990 Apr; 527(1):134-9. PubMed ID: 2365771
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of delta-aminolevulinic acid in blood plasma and urine by gas-liquid chromatography.
    MacGee J; Roda SM; Elias SV; Lington A; Tabor MW; Hammond PB
    Biochem Med; 1977 Feb; 17(1):31-44. PubMed ID: 843341
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of 5-aminolaevulinic acid by reversed phase HPLC and fluorescence detection.
    Minder EI
    Clin Chim Acta; 1986 Nov; 161(1):11-8. PubMed ID: 3815852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorometric HPLC determination of delta-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure.
    Oishi H; Nomiyama H; Nomiyama K; Tomokuni K
    J Anal Toxicol; 1996; 20(2):106-10. PubMed ID: 8868401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of delta-aminolevulinic acid analysis in clinical tests].
    Sassa S
    Nihon Rinsho; 1989 Dec; 48 Suppl():690-3. PubMed ID: 2621983
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects.
    Morita Y; Araki S; Sakai T; Araki T; Masuyama Y
    Ind Health; 1994; 32(2):85-96. PubMed ID: 7806449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the determination of delta-aminolevulinic acid in plasma and blood, the effect of sample storage, and the comparison between both values].
    Morita Y; Sakai T; Araki S; Araki T; Masuyama Y
    Sangyo Igaku; 1993 Nov; 35(6):538-9. PubMed ID: 8277592
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimized liquid-chromatographic method for fluorometric determination of urinary delta-aminolevulinic acid in workers exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y; Hasegawa T
    Clin Chem; 1987 Sep; 33(9):1665-7. PubMed ID: 3621570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvement of urinary delta-aminolevulinic acid determination by HPLC-fluorometry using pre-column derivatization].
    Endo Y; Okayama A; Endo G; Horiguchi S; Nakazono N
    Sangyo Igaku; 1993 Mar; 35(2):126-7. PubMed ID: 8510345
    [No Abstract]   [Full Text] [Related]  

  • 12. A reference value for delta-aminolevulinic acid in plasma in the population occupationally unexposed to lead.
    Morita Y; Sakai T; Araki T; Suzuki K; Oda K; Araki S; Masuyama Y
    Ind Health; 1996; 34(1):57-60. PubMed ID: 8707623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of colorimetric and HPLC methods for determination of delta-aminolevulinic acid in urine with reference to dose-response relationship in occupational exposure to lead.
    Fukui Y; Miki M; Ukai H; Okamoto S; Takada S; Ikeda M
    Ind Health; 2005 Oct; 43(4):691-8. PubMed ID: 16294925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelation between urinary delta-aminolevulinic acid (ALA), serum ALA, and blood lead in workers exposed to lead.
    Tomokuni K; Ichiba M; Fujishiro K
    Ind Health; 1993; 31(2):51-7. PubMed ID: 8226113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorometric measurement of 5-aminolevulinic acid in serum.
    Lee C; Qiao X; Goeger DE; Anderson KE
    Clin Chim Acta; 2004 Sep; 347(1-2):183-8. PubMed ID: 15313157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
    Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P
    Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 5-aminolevulinic acid in biological samples by high-performance liquid chromatography.
    Meisch HU; Reinle W; Wolf U
    Anal Biochem; 1985 Aug; 149(1):29-34. PubMed ID: 3840960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delta-Aminolevulinic acid in urine (screening method)].
    Tomokuni K
    Nihon Rinsho; 1995 Jun; 53(6):1383-8. PubMed ID: 7616651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-aminolevulinic acid in plasma by free amino acid analysis.
    Hannan CJ; Kettler T; Dabe I; Clark T
    Clin Chem; 1989 Sep; 35(9):1998. PubMed ID: 2776336
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical dose of lead affecting delta-aminolevulinic acid levels.
    Murata K; Sakai T; Morita Y; Iwata T; Dakeishi M
    J Occup Health; 2003 Jul; 45(4):209-14. PubMed ID: 14646278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.